JB
APEN

Julian Baker’s Apollo Endosurgery, Inc. APEN Stock Holding History

Julian Baker’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-2,597
Closed -$880K – 83
2013
Q2 		$880K Buy
+2,597
New +$976K 0.02% 70

Other funds holding APEN

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return

Julian Baker's APEN Position: Q3 2013 in Review

Julian Baker sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2013, closing a stake of 2,597 shares — an estimated $880K sold.

Julian Baker first reported a position in APEN in Q2 2013 and held it in 1 quarter. The position peaked at $880K in Q2 2013. 13 funds tracked by Wall St. Rank hold APEN as of Q3 2013.

  • Julian Baker reported no remaining Apollo Endosurgery, Inc. position as of Q3 2013 after selling out during the quarter.
  • Julian Baker sold 2,597 Apollo Endosurgery, Inc. shares in Q3 2013, an estimated $880K.
  • Julian Baker first reported a position in Apollo Endosurgery, Inc. in Q2 2013 and held it in 1 quarter.
  • Julian Baker's Apollo Endosurgery, Inc. position peaked at $880K in Q2 2013.
  • 13 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2013.

Based on Baker Bros. Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.